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Asthma is one of the most prevalent chronic 
health conditions in Canadian children. The 
1998–1999 National Population Health 
Survey found that the prevalence of physi-
cian-diagnosed asthma is 8.4% among the 
whole population and 10.7% among children 
and teenagers, corresponding to approxi-
mately 845,000 children (Canadian Institute 
for Health Information et al. 2001). Asthma 
compromises the quality of life for patients 
and their families and imposes a burden on 
the nation’s health care expenditure. In 1990, 
the economic costs of asthma for Canada 
were estimated to fall between $504 and $648 
million (Krahn et al. 1996).
Epidemiologic studies have shown that 
air pollution is associated with asthma-related 
increases in hospital admissions (Burnett 
et al. 1999; Wong et al. 2001), emergency 
department visits (Stieb et al. 2000; Sunyer 
et al. 1997; Villeneuve et al. 2007), and 
respiratory symptoms (Brauer et al. 2002; 
Vichit-Vadakan et al. 2001), and decreases 
in pulmonary function (Delfino et al. 2004; 
Gielen et al. 1997). However, there is a dearth 
of information about whether these associa-
tions can be attributed to lung tissue injury in 
an asthmatic population, partly because of the 
lack of appropriate non-invasive biomarkers 
indicating lung inflammation and tissue 
injury. In recent years, some researchers have 
used fractional exhaled nitric oxide (FeNO) to 
investigate the relationship between exposure 
to air pollutants and airway inflammation 
(Delfino et al. 2006; Mar et al. 2005). 
Measurements of mediators in exhaled 
breath condensate have been used to better 
understand the pathological mechanisms of air-
way diseases such as asthma, chronic obstructive 
pulmonary disease, and cystic fibrosis (Horvath 
et al. 2005; Montuschi 2005). Recently, analy-
sis of mediators in condensed breath has been 
extended to include lung diseases caused by 
occupational exposure (Lehtonen et al. 2007; 
Pelclová et al. 2007). Asthma is a chronic air-
way inflammatory disease involving a variety 
of inflammatory cell types and proinflamma-
tory mediators. Reactive oxygen species are 
also thought to play an active role in inducing 
airway inflammation and hyperresponsivness 
(Hulsmann et al. 2007). Reactive oxygen species 
result from an increased burden of exogenous 
oxidants, endogenous lipid peroxidation, as 
well as from inflammatory cells (Halliwell and 
Gutteridge 1989). The level of reactive oxygen 
species in the airways can be determined by 
assaying concentrations of oxidative stress mark-
ers in breath condensate (Horvath et al. 2005).
We designed this longitudinal study to 
test the hypothesis that an acute increase 
in ambient air pollutants is associated with 
increased levels of markers of oxidative stress 
and inflammation in breath condensate of 
children with asthma, and that changes of 
breath markers are consistent with changes in 
pulmonary function and FeNO.
Materials and Methods
Study subjects. The study protocol was 
approved by the Research Ethics Board of 
Health Canada. The parent of each child gave 
written informed consent before the child’s 
participation in this study.
The study was conducted between 
October and December of 2005 in Windsor, 
Ontario, Canada. Asthmatic children, 9 to 
14 years of age, from nonsmoking households, 
were identified from a questionnaire survey 
of grades one to eight of elementary school-
children whose parents were asked whether or 
not the child had doctor-diagnosed asthma. 
The parents who gave a positive response were 
telephoned to confirm the child’s current sta-
tus of doctor-diagnosed asthma and whether 
there was any smoking of tobacco products 
in the household. One hundred eighty two 
subjects agreed to participate in this longitudi-
nal study. Information on family income and 
family asthma history was extracted from the 
survey questionnaire. For logistical purposes, 
children were studied in two test periods, 
either between 11 October and 11 November 
(95 children), or between 14 November and 
9 December 2005 (87 children). We did not 
advise parents to alter their children’s daily 
activity and the use of asthma medications.
Ambient air pollution monitoring. Hourly 
measures of particulate matter ≤ 2.5 µm in 
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ba c K g r O u n d: Air pollution is associated with respiratory symptoms, lung function decrements, and 
hospitalizations. However, there is little information about the influence of air pollution on lung injury. 
Ob j e c t i v e: In this study we investigated acute effects of air pollution on pulmonary function and 
airway oxidative stress and inflammation in asthmatic children.
Me t h O d s : We studied 182 children with asthma, 9–14 years of age, for 4 weeks. Daily ambi-
ent concentrations of sulfur dioxide, nitrogen dioxide, ozone, and particulate matter ≤ 2.5 µm 
in aerodynamic diameter (PM2.5) were monitored from two stations. Once a week we measured 
spirometry and fractional exhaled nitric oxide (FeNO), and determined thiobarbituric acid reactive 
substances (TBARS) and 8-isoprostane—two oxidative stress markers—and interleukin-6 (IL-6) 
in breath condensate. We tested associations using mixed-effects regression models, adjusting for 
confounding variables.
re s u l t s: Interquartile-range increases in 3-day average SO2 (5.4 ppb), NO2 (6.8 ppb), and PM2.5 
(5.4 µg/m3) were associated with decreases in forced expiratory flow between 25% and 75% of forced 
vital capacity, with changes being –3.1% [95% confidence interval (CI), –5.8 to –0.3], –2.8% (95% 
CI, –4.8 to –0.8), and –3.0% (95% CI, –4.7 to –1.2), respectively. SO2, NO2, and PM2.5 were asso-
ciated with increases in TBARS, with changes being 36.2% (95% CI, 15.7 to 57.2), 21.8% (95% CI, 
8.2 to 36.0), and 24.8% (95% CI, 10.8 to 39.4), respectively. Risk estimates appear to be larger in 
children not taking corticosteroids than in children taking corticosteroids. O3 (5.3 ppb) was not asso-
ciated with health end points. FeNO, 8-isoprostane, and IL-6 were not associated with air pollutants. 
cO n c l u s i O n: Air pollution may increase airway oxidative stress and decrease small airway function of 
asthmatic children. Inhaled corticosteroids may reduce oxidative stress and improve airway function.
Key w O r d s : air pollution, asthma, children, exhaled breath condensate, inflammation, oxidative 
stress, pulmonary function. Environ Health Perspect 117:668–674 (2009).  doi:10.1289/ehp11813 
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aerodynamic diameter (PM2.5), sulfur dioxide, 
nitrogen dioxide, and ozone were available 
from the National Air Pollution Surveillance 
network of Environment Canada (http://www.
etc-cte.ec.gc.ca/NapsData). There were two 
monitoring stations representing Windsor, 
located upwind from the prevailing winds. Of 
182 participating children, 180 of them lived 
within a 10-km radius from the air monitoring 
sites, and one lived 12 km and another 17 km 
from the air sampling sites (Figure 1). Values 
from these two monitors were averaged. SO2 
was measured using ultraviolet fluorescence 
and the electrical conductivity from changes in 
chemical composition of a bromine solution, 
NO2 measured using chemiluminescence, O3 
measured using ultraviolet absorbance, and 
PM2.5 measured using tapered element oscil-
lating microbalance monitor. Pollutant con-
centrations were averaged over a 24-hr period. 
Measurement of spirometry and FeNO. 
Once a week, registered respiratory tech-
nologists visited the children’s schools, and 
conducted tests of spirometry and FeNO and 
collected exhaled breath condensate on study 
participants. These tests were run on the same 
day of the week for each child.
Spirometry was performed according to 
American Thoracic Society criteria (American 
Thoracic Society 1995). KoKo Spirometers 
(Ferraris CardioRespiratory; Pulmonary Data 
Services, Inc. Louiseville, CO, USA) were cal-
ibrated daily and results adjusted for tempera-
ture and barometric pressure. A maximum 
of eight forced vital capacity (FVC) maneu-
vers were carried out in an attempt to achieve 
three acceptable flow-volume loops and two 
being within 0.20 L for FVC and forced expi-
ratory volume in one second (FEV1), and 
within 0.20 L/sec for the mean forced expira-
tory flow between 25% and 75% of the FVC 
(FEF25–75%). The value assigned to the child 
was the largest acceptable value within 200 
mL of a second value.
Single-breath on-line measures of FeNO 
were carried out according to American 
Thoracic Society and European Respiratory 
Society Guidelines (American Thoracic 
Society 2005) using an Eco Physics CLD 
AL MED chemiluminescence analyzer (Eco 
Medics AG, Duernten, Switzerland). Before 
performing a slow vital capacity maneuver 
over at least 6 sec at 0.05 L/sec, subjects took 
three tidal volume breaths through a DENOX 
88 (Eco Medics AG, Duernten, Switzerland) 
which contains an NOx absorber cartridge to 
scrub the ambient air to a value of between 
0 and 1.5 ppb. The test was repeated a maxi-
mum of eight times in an attempt to obtain 
at least two acceptable plateau FeNO values 
within 10%. The value assigned to the subject 
was the mean of the two values. We calculated 
FeNO statistics using spiroWare 88 software 
(Eco Medics AG, Duernten, Switzerland). 
Collection of exhaled breath condensate, 
and measurement of amylase, oxidative stress, 
and inflammation. Exhaled breath condensate 
was collected using an RTube (Respiratory 
Research Inc., Charlottesville, VA, USA). 
Participants sat and breathed at tidal vol-
umes orally into a mouthpiece attached to a 
cold condenser, for 10 min. Approximately 
1 mL of breath condensate was collected. The 
condensed breath was then transferred into 
a microtube and stored at –20°C and then 
–80°C until use.
To determine saliva contamination, we 
measured α-amylase activity in breath conden-
sate using an assay kit (Pointe Scientific, MI, 
USA), which follows the increase in absorbance 
at 405 nm as the artificial substrate 2-chloro-p-
nitrophenyl-α-d-maltotrioside is hydrolyzed. 
Thiobarbituric acid reactive substances 
(TBARS) were determined in duplicate by 
a fluorescence method adapted from Yagi 
(1982). We used malonaldehyde bis-(dimethyl 
acetal) (Aldrich Chemical Co., Milwaukee, 
WI, USA) to construct a standard curve. To 
reduce the background interference with the 
very low levels of TBARS present in exhaled 
breath condensates, all glassware was washed 
in soap-free detergent followed by rinsing 
with distilled water and ethanol before use. 
We used butanol (OmniSolv, 99.95%; EM 
Science, Darmstadt, Germany) for extraction. 
The n-butanol extract was transferred to a 
Whatman glass bottom microplate (Whatman, 
NJ, USA), previously washed with ethanol, 
and the fluorescence measured at 530 nm/590 
nm, excitation/emission, with a Cytofluor 
2350 reader (Millipore, Billerica, MA, USA). 
The detection limit was 0.02 µM (three times 
the standard deviation above the blank). The 
within-run coefficient of variation was 8%.
A colorimetric enzyme immunoassay kit 
(Cayman Chemical, Ann Arbor, MI, USA) 
was used to measure 8-isoprostane concentra-
tions in breath condensate. The assays were 
done in triplicate. A modified standard curve 
for 8-isoprostane was established for concen-
trations between 0.975 and 62.5 pg/mL. We 
were able to detect 8-isoprostane at a concen-
tration as low as 0.975 pg/mL (three times 
the standard deviation above the blank). The 
within-run coefficient of variation was 5%. 
We also measured 8-isoprostane on 8 random 
samples using radioimmunoassay, a proce-
dure previously described by Montuschi et al. 
(2003), and compared the results from both 
methods [see Supplemental Material, Table 1 
(available online at http://www.ehponline.org/
members/2008/11813/suppl.pdf)]. Pearson 
correlation coefficient for results from two 
methods was 0.744 (p = 0.055), with a mean 
positive bias of approximately 35% in favor 
of the radioimmunoassay. Such a difference 
may be attributed to variations in the avidity 
and specificity of the antibodies used and the 
inherent variation during extrapolation from 
calibration curves at very low levels that were 
typical of exhaled breath condensates. 
We determined the level of interleukin-6 
(IL-6) using an ELISA kit from R&D Systems 
(Minneapolis, MN, USA). We conducted the 
ELISA assays in duplicate by following manu-
facturer’s instructions accompanying the kit. 
The detection limit was 0.48 pg/mL.
Statistical analysis. We analyzed the corre-
lations among environmental factors, daily use 
of inhaled corticosteroids (ICS) or short-acting 
Figure 1. Map of Windsor, Ontario, Canada. 
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β-agonist (SABA), and testing period, using 
Spearman rank order correlation, because 
some variables were not normally distributed. 
We used mixed-effects regression models to 
account for repeated measures and to analyze 
the associations between pollutants and health 
end points, assuming random slope and ran-
dom intercepts, and accounting for intraindi-
vidual correlation using S-PLUS (version 6.1; 
Insightful Corporation, Seattle, WA, USA). 
Data for FeNO, TBARS, and 8-isoprostane 
were log-transformed to fit a normal distribu-
tion. Because > 99% of the samples gave a 
value > 0 for TBARS and 8-isoprostane, and 
most of them were above the detection limit, 
data points below the detection limit were not 
given special treatment. For exposure variables, 
we tested models for multiday moving aver-
ages to examine potentially delayed response. 
Models were adjusted for time-dependent 
covariates that were statistically associated with 
either the exposure or response. We adjusted 
for testing period (as an indicator variable) 
to reduce the impact of seasonality. We also 
included product terms for the interaction of 
pollutant concentrations with sex and with the 
use of ICS to test potential modifying effects 
of sex and ICS. Since subjects served as their 
own control, we did not adjust for factors 
which remained constant during the study 
period such as age, race, family income, and 
family asthma history. Because health testing 
was kept on the same day of week for each 
child, we did not adjust for the effect of day-
of-week in the models. 
When interactions were detected between 
pollutants and sex or the use of ICS, the par-
ticipants were stratified for further analyses. 
We also ran two-pollutant models to adjust 
for potential confounding effects of co-pol-
lutants. Results were expressed as percent 
change in FEV1, FEF25–75%, FeNO, TBARS 
and 8-isoprostane per increase in inter- nd 8-isoprostane per increase in inter- per increase in inter-
quartile-range concentration of a pollutant. 
A two-tailed value of p ≤ 0.05 was considered 
statistically significant.
Results
A total of 182 asthmatic children participated 
in the study, for a total of 691 spirometry test 
results, 672 FeNO test results, and 616 breath 
samples. Seven children had 5 measurement 
days, 142 had 4 days, 27 had 3 days, and 6 had 
2 days. In total, there were 39 meas  urement 
days during the study period, and no missing 
day for air monitoring to match health testing 
days. The characteristics of this cohort are pre-
sented in Table 1. We meas  ured the concen-
tration of amylase in 25% of breath samples to 
determine saliva contamination. The median 
amylase concentration was 0.60 unit/L, with 
the 95th percentile being 1.46 unit/L. None 
of the samples had amylase concentrations 
near the reported salivary amylase concentra-
tion of 1,250 unit/L (Brand et al. 2006). We 
estimated that saliva contamination was likely 
< 0.1%, and therefore interference of breath 
analysis by saliva was negligible. In 616 breath 
samples, only 2 samples had detectable IL-6 
levels. We therefore did not conduct further 
analysis on IL-6. 
The environmental conditions and daily 
concentrations of air pollutants measured dur-
ing the study period are presented in Table 2. 
Because Spearman rank order correlation 
analyses showed that daily temperature, rela-
tive humidity and testing period were signifi-
cantly correlated with some of the pollutants 
(Table 3), we included these variables in mod-
els to adjust for any confounding/modifying 
effects. We also included daily use of SABA 
and ICS to adjust for their potential confound-
ing effects. Because pollutants were correlated 
with each other (Table 3), we also ran two-
pollutant models to adjust for   confounding.
Results from single-pollutant regression 
models. Table 4 presents percentage changes 
of health end points in relation to an increase 
in interquartile range concentrations of pol-
lutants in a single-pollutant model which also 
included interaction terms of ICS and sex 
with pollutants. FEV1 and FEF25–75% exhib-
ited a consistent trend of negative associa-
tions with all four pollutants, with FEF25–75% 
Table 1. Selected characteristics of 182 asthmatic children from Windsor, Ontario, Canada.
Characteristic     Value
Age (years) [median (range)]    11 (9–14)
Sex [no. (%)] 
  Female    68 (37.4)
  Male    114 (62.6)
Race [no. (%)] 
  Caucasian    160 (87.9)
  Other    22 (12.1)
Parental asthma [no. (%)] 
  No    11 (6.0)
  Yes    70 (38.5)
  Unknown    101 (55.5)
Self-reported medication usea [no. (%)] 
  ICS    68 (37.4)
  SABA    64 (35.2)
  Other asthma medications    33 (18.1)
  None    77 (42.3)
FEV1 (L) [median (5th– 95th percentile)]    2.4 (1.7–3.3)
Percent predicted FEV1 (%) [median (5th– 95th percentile)]b    90.5 (68.6–107.1)
FEF25–75% (L/sec) [median (5th– 95th percentile)]    2.5 (1.3–3.9)
Percent predicted FEF25–75% (%) [median (5th– 95th percentile)]b    78.2 (45.3–118.0)
FeNO (ppb) [median (5th– 95th percentile)]    19.4 (4.5–81.6)
TBARS (µM) [median (5th– 95th percentile)]    0.26 (0.03–1.53)
8-Isoprostane (pg/mL) [median (5th– 95th percentile)]    1.43 (0.30–4.20)
aMore than one medication could be used. bPredicted normal values were calculated based on a given height, age, sex, 
and race/ethnicity (Hankinson et al. 1999).
Table 2. Values for selected environmental conditions during study period.
  Median [interquartile range (5th–95th percentile)]
Environmental variable  1-day average  2-day average  3-day average
SO2 (ppb)  4.5 [6.5 (0.5 to 15.5)]  5.0 [5.6 (1.0 to 13.0)]  5.6 [5.4 (1.3 to 13.8)]
NO2 (ppb)  19.8 [9.8 (9.5 to 29.5)]  18.3 [9.0 (11.3 to 28.0)]  18.3 [6.8 (12.3 to 27.0)]
O3 (ppb)  13.0 [9.0 (6.5 to 26.5)]  14.1 [6.4 (6.8 to 23.3)]  14.0 [5.3 (7.5 to 21.0)]
PM2.5 (µg/m3)  6.5 [6.0 (2.0 to 19.0)]  6.6 [6.4 (2.0 to 15.0)]  6.9 [5.4 (2.7 to 14.3)]
Temperature (°C)  6.6 [13.0 (–7.7 to 15.4)]  7.4 [12.0 (–5.5 to 14.7)]  7.4 [11.2 (–5.9 to 14.5)]
Relative humidity (%)  67.4 [11.6 (53.3 to 87.9)]  65.6 [9.7 (54.4 to 75.6)]  65.7 [7.3 (54.9 to 74.2)]
Air quality was monitored between 8 October and 9 December 2005, 62 sampling days.
Table 3. Spearman rank order correlation coefficients of variables.
    Relative
Variable  Temperature  humidity  SO2  NO2 O 3  PM2.5  SABA  ICS
Testing period  –0.73*  0.01  0.35*  –0.30*  0.06  –0.07  0.10*  –0.07
Temperature    0.18*  –0.17*  0.00  0.18*  0.10*  –0.10*  –0.02
Relative humidity      –0.04  0.03  –0.51*  0.20*  0.01  –0.02
SO2        0.18*  –0.02  0.56*  0.04  0.05
NO2          –0.51*  0.71*  –0.04  0.07
O3            –0.41*  0.00  –0.10*
PM2.5              –0.05  0.07
SABA                0.27*
*p < 0.05.Air pollution is linked to lung injury in asthmatic children
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 4 | April 2009  671
having a statistically significant association 
with NO2 and PM2.5. The significant asso-
ciations for FEF25–75% persisted for at least 
3 days. FeNO had a trend of positive asso-
ciations with SO2, NO2, and PM2.5, but the 
associations were not statistically significant. 
FeNO had a statistically significant negative 
association with O3. TBARS was significantly 
positively associated with SO2, NO2, and 
PM2.5, but not with O3. The associations for 
TBARS persisted for at least 3 days. 8-Iso-
prostane was significantly positively associated 
with same-day SO2, but not associated with 
other pollutants.
Modifying effects by the use of ICS and 
sex. Product terms between pollutants and the 
use of ICS showed significant interactions for 
some of the health end points. For example, 
the product term for SO2 and ICS was posi-
tively associated with TBARS (p = 0.04), but 
negatively associated with FEV1 (p < 0.01), 
FEV25–75% (p = 0.02), and 8-isoprostane (p 
= 0.01), indicating that the use of ICS was a 
significant effect modifier. The participants 
were then stratified by the use of ICS dur-
ing the study period to adjust for modifying 
effects of use of ICS (Figure 2). Children who 
did not use ICS appeared to have larger risk 
estimates for pollutants than did those who 
used ICS. Among children not taking ICS, 
risk estimates for pollutants were statistically 
significant with respect to FEV1, FEF25–75%, 
and TBARS. Risk estimates for FeNO and 
8-isoprostane were not very different between 
the two groups of children (data not shown).
Product terms for pollutants and sex 
showed no significant interaction (p > 0.05), 
suggesting that sex was not a significant modi-
fier for the associations between air pollutants 
and health end points. We therefore did 
not run further analysis on boys and girls 
  separately.
Results from two-pollutant models. 
Because we found consistent associations with 
pollutants for FEV1, FEF25–75%, FeNO, and 
TBARS, we ran two-pollutant models on 
these end points to adjust for confounding 
effects of co-pollutants (Figure 3). For FEV1 
and FEF25–75%, although two-pollutant mod-
els did not result in marked changes in risk 
estimates for PM2.5 and O3, including PM2.5 
in models did somewhat change risk esti-
mates for SO2 and NO2, suggesting that the 
effects of SO2 and NO2 on pulmonary func-
tion were influenced by PM2.5. For FeNO and 
TBARS, including two pollutants in models 
did not markedly change the regression results, 
Table 4. Percent change (95% confidence interval) in health end points of 182 asthmatic children, in association with an interquartile-range increase of a pollut-
ant, in single–pollutant models with various lag times. 
Air pollutant  FEV1  FEF25–75%  FeNO  TBARS  8–Isoprostane
SO2 
  Same day   –0.3 (–1.3 to 0.7)   –1.0 (–3.1 to 1.3)  5.8 (–5.0 to 17.8)  17.4 (0.3 to 37.4)*  14.1 (2.5 to 26.9)*
  Lag 1 day   0.1 (–1.1 to 1.2)  –0.9 (–3.1 to 1.4)  1.6 (–9.3 to 13.9)  14.1 (–1.8 to 32.5)  –2.4 (–11.7 to 7.9)
  2-day average  –0.1 (–1.4 to 1.3)  –1.8 (–4.7 to 1.1)  5.9 (–9.3 to 23.7)  35.1 (9.5 to 66.8)*  9.4 (–5.2 to 26.2)
  3-day average   –0.3 (–1.9 to 1.4)   –2.3 (–5.5 to 1.0)  1.7 (–14.1 to 20.3)  61.8 (24.9 to 109.5)*  –0.3 (–16.4 to 18.9
NO2 
  Same day  –0.6 (–1.6 to 0.3)  –2.4 (–4.3 to –0.4)*  8.2 (–2.9 to 20.6)  21.2 (1.9 to 44.2)*  0.0 (–10.7 to 12.1)
  Lag 1 day   –0.3 (–1.1 to 0.6)  –1.4 (–3.1 to 0.3)  3.7 (–6.1 to 14.6)  10.2 (–5.6 to 28.7)  –5.6 (–14.8 to 4.5)
  2-day average  –0.6 (–1.6 to 0.4)  –2.4 (–4.3 to –0.3)*  7.4 (–4.6 to 21.0)  20.3 (–0.4 to 45.3)   –4.7 (–1.1 to 8.1)
  3-day average  –0.8 (–1.9 to 0.3)   –2.8 (–5.0 to –0.5)*  0.5 (–12.1 to 14.9)  32.9 (7.2 to 64.6)*   –4.0 (–16.3 to 10.2)
O3
  Same day   –0.4 (–1.6 to 0.7)  0.2 (–2.1 to 2.5)  –12.2 (–22.3 to –0.8)*  5.0 (–13.2 to 27.0)  7.0 (–6.5 to 22.4)
  Lag 1 day   –0.2 (–1.1 to 0.7)  0.1 (–1.7 to 1.9)   –8.3 (–16.0 to 0.2)  7.3 (–6.7 to 23.4)  6.6 (–3.4 to 17.6)
  2-day average  –0.4 (–1.6 to 0.9)  0.4 (–2.2 to 3.0)  –16.0 (–26.4 to –4.1)*  14.4 (–8.5 to 43.0)  12.0 (–3.8 to 30.5)
  3-day average   –0.5 (–2.0 to 1.0)  –0.4 (–3.5 to 2.7)  –1.6 (–16.7 to 16.1)  8.8 (–17.4 to 43.4)  15.9 (–3.5 to 39.1)
PM2.5
  Same day  –0.5 (–1.3 to 0.3)  –1.9 (–3.5 to –0.3)*  5.3 (–3.6 to 15)  16.9 (2.2 to 33.6)*  5.1 (–3.6 to 14.5)
  Lag 1 day  –0.3 (–1.1 to 0.5)  –1.2 (–2.8 to 0.3)  1.7 (–6.3 to 10.4)  14.6 (0.8 to 30.4)*  –3.8 (–12.1 to 5.3)
  2-day average  –0.6 (–1.5 to 0.4)  –2.0 (–3.8 to –0.2)*  4.3 (–5.4 to 15.1)  22.0 (4.8 to 42.1)*  0.1 (–9.8 to 11.1)
  3-day average  –1.1 (–3.1 to 0.9)  –3.3 (–7.2 to 0.8)  –17.3 (–33.5 to 2.9)  69.1 (20.1 to 138.2)*  5.8 (–15.8 to 33.0)
2-day average: the median concentration of a pollutant collected on the day and 1 day before the clinical testing was done. 3-day average: the median concentration of a pollutant col-
lected on the day and 2 days before the clinical testing was done. Models were adjusted for testing period, daily temperature, relative humidity, and use of SABA and ICS. Interaction 
terms were included in the models to test modifying effects of taking ICS (a binary indicator) and sex (binary indicator) on air pollutants. 
*p < 0.05.
Figure 2. Percent changes and 95% confidence intervals in FEV1 (A), FEF25–75%(B), FeNO (C), and breath 
TBARS (D) of asthmatic children taking or not taking ICS during the study period, in association with an 
interquartile-range increase in a pollutant. Sixty-eight asthmatic children took (Yes), and 114 children did 
not take (No) ICS. Pollutant concentrations were averaged over 3 days including the same day and 2 days 
before the clinical testing was done. Models were adjusted for testing period, daily temperature, relative 
humidity, and use of SABA. 
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suggesting that the results of each pollutant 
were independent of other pollutants.
Discussion
Principal findings of this study are that SO2, 
NO2, and PM2.5 in ambient air were signifi-
cantly associated with decrements in FEV1 and 
FEF25–75%, and increases in TBARS in breath 
condensate among children with asthma. The 
risk estimates were larger for pollutant con-
centrations averaged over 3 days than over a 
shorter term. Clinically FEF25–75% has been 
considered to be sensitive in detecting small 
airway dysfunction (Lebecque et al. 1993). 
These associations were robust after inclusion 
of daily temperature, relative humidity, study 
period, and the use of asthma medications 
SABA and ICS in models. The associations for 
O3 and PM2.5 were not sensitive to inclusion 
of co-pollutants, as adjusting for other pol-
lutants in the model did not markedly change 
the strength of the risk estimates for O3 and 
PM2.5. The associations between pulmonary 
function decrements and SO2 and NO2 were 
sensitive to the inclusion of PM2.5 in models, 
suggesting that PM2.5 may have confounded 
some of the effects of SO2 and NO2. Adverse 
changes in FEF25–75% were consistent with 
those of TBARS in response to SO2, NO2, 
and PM2.5 with a similar lag structure, sug-
gesting a coherent outcome for small airway 
function and oxidative stress. Our results on 
pulmonary function changes were similar 
to those published previously (Delfino et al. 
2004; Epton et al. 2008; Gielen et al. 1997; 
Romieu et al. 2008), although air pollutant 
levels in the present study were low compared 
to those studies.
Exhaled breath condensate has been 
used in clinical settings to study pathologi-
cal mechanisms of respiratory illness such as 
asthma, chronic obstructive pulmonary dis-
ease, and cystic fibrosis (Baraldi et al. 2003; 
Horvath et al. 2005). Elevated concentra-
tions of oxidant nitrate (Balint et al. 2001), 
IL-6 and leukotriene B4 (Carpagnano et al. 
2003), and 8-isoprostane (Montuschi et al. 
2000), have been found in breath condensate 
of adult smokers. Markers of inflammation 
and oxidative stress in breath were associated 
with occupational exposure to cobalt and 
tungsten (Goldoni et al. 2004), chromium 
(Caglieri et al. 2006), silica (Pelclová et al. 
2007), and asbestos (Lehtonen et al. 2007). 
Montuschi et al. (2002) exposed healthy 
nonsmoking adults to high concentration of 
O3 (400 ppb) and clean air for 2 hr on sep-
arate occasions in a laboratory setting, and 
reported that exposure to O3 led to a signifi-
cant increase in 8-isoprostane concentrations 
in breath condensate. Barregard et al. (2008) 
exposed adult human subjects to wood smoke 
in a controlled environment and reported an 
increase in malondialdehyde levels in breath 
for at least 20 hr postexposure. However, lit-
tle work has been done to use biomarkers in 
breath condensate to examine the effects of 
ambient air pollutants on airway inflamma-
tion and oxidative stress among asthmatic 
children. Very recently, Epton et al. (2008) 
reported a cohort study on 12- to 18-year-old 
male healthy and asthmatic students in a New 
Zealand boarding school, where they found 
small effects of PM10 (PM with aerodynamic 
diameter < 10 µm) in ambient air on FEV1, 
but no effect on pH and hydrogen peroxide 
in exhaled breath. However, with a panel of 
asthmatic children living in Mexico City, 
Romieu et al. found an association between 
malondialdehyde in exhaled breath and PM2.5 
and O3 in ambient air (Romieu et al. 2008). 
A 14.2-µg/m3 (interquartile-range) increase 
in 8-hr moving average PM2.5 was signifi-
cantly associated with a 1.12-nmol increase 
in malondialdehyde, while a 15.9-ppb (inter-
quartile-range) increase in 8-hr moving aver-
age O3 was significantly associated with a 
1.16-nmol increase in malondialdehyde. Our 
results are consistent with these findings in 
that inhaled ambient air pollutants were sig-
nificantly associated with an increase in an 
oxidative stress marker in breath condensate. 
Oxidative stress–inducing reactive oxygen 
species are physiologically active mediators 
that can be induced by air pollutants. PM2.5, 
SO2, NO2, and O3 have been demonstrated 
to cause formation of excessive amount of 
reactive oxygen species in airways and in the 
cardiovascular system in experimental animals, 
leading to tissue inflammation and cell death 
(Dye et al. 1997; Meng et al. 2003; Persinger 
et al. 2002). Oxidative stress has been linked 
to clinical phenotypes such as asthma and 
atherosclerosis (Chuang et al. 2007; Walter 
et al. 2004). TBARS are a group of low-
molecular-weight chemicals that are formed 
during the decomposition of lipid peroxida-
tion products (Halliwell and Chirico 1993), 
and thus are often used as an index of lipid 
peroxidation and oxidative stress (Kodavanti 
et al. 2000; Rhoden et al. 2004; Walter et al. 
2004). 8-Isoprostane is a prostaglandin F2α–
like compound produced by free radicals via 
the nonenzymatic peroxidation of arachidonic 
acid in membrane phospholipids (Morrow 
et al. 1990). Because TBARS are derived 
from oxidative degradation of a broader range 
of biological substances including lipids and 
sugars than is 8-isoprostane (Halliwell and 
Gutteridge 1981; Janero 1990), and because 
we observed an increase in TBARS but not 
8-isoprostane in breath samples in relation to 
elevated air pollutants, it appears that TBARS 
may be a more sensitive biomarker than 8-iso-
prostane in breath condensate as a useful tool 
for investigating air pollution-related oxidative 
stress among asthmatic children, especially for 
acute exposures. It remains to be seen whether 
immunoassays with significantly higher sensi-
tivity and specificity can improve the efficacy 
of 8-isoprostane as a biomarker of oxidative 
stress in exhaled breath condensate. 
ICS are thought to reduce inflamma-
tion and oxidative stress in airways (Baraldi 
et al. 2003; Khor et al. 2007). Children with 
asthma exacerbation have reduced 8-isopros-
tane in breath condensate after ICS treatment 
(Baraldi et al. 2003). In the present study, we 
found that ICS seems to be able to reduce 
some of the adverse effects of air pollutants, 
Figure 3. Percent changes and 95% confidence intervals in FEV1 (A), FEF25–75%(B), FeNO (C), and breath 
TBARS (D) of asthmatic children, in association with an interquartile-range increase in a pollutant, in one- 
and two-pollutant models. Pollutant concentrations were averaged over 3 days including the same day 
and 2 days before the clinical testing was done. Models were adjusted for testing period, daily tempera-
ture, relative humidity, and use of SABA and ICS. 
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as the risk estimates appear to be larger for 
the children who did not take ICS during the 
study period. Consistent with our findings, 
previous studies have also reported stronger 
associations between exposure to air pollutants 
and decrements in pulmonary function and 
increases in FeNO for children not taking anti-
inflammatory medications than for children 
taking the medications (Delfino et al. 2006, 
2008; Mar et al. 2005). In the present study 
only 37% of children used ICS, which could 
result in a reduced statistical power to detect 
associations with pollutants in this group. 
Oxidative stress often occurs along with 
tissue inflammation, which induces the 
release of reactive oxygen species to cause tis-
sue injury (Chuang et al. 2007; Dye et al. 
1997; Kodavanti et al. 2000). Unlike previ-
ously published studies (Delfino et al. 2006; 
Mar et al. 2005), in our study we did not 
find statistically significant adverse changes in 
inflammatory marker FeNO associated with 
air pollution, and the level of IL-6 in breath 
condensate was too low to be detectable. One 
interpretation for the results of inflamma-
tion markers was that we might need a larger 
sample size to detect significant changes in 
airway inflammation. Another possible expla-
nation might be that the inflammation in 
lower airways of the children was not captured 
by FeNO measured at a flow rate of 0.05 L/
sec; Barregard et al. (2008) reported that 
exposure to wood smoke particles resulted 
in significant increase in FeNO measured at a 
flow rate of 0.27 L/sec, but not at 0.05 L/sec. 
Alternatively, this group of asthmatic chil-
dren might have been in such a state of airway 
inflammation that it overwhelmed the effects 
of air pollution, particularly when exposure 
concentrations were lower than those in other 
studies (Delfino et al. 2006; Mar et al. 2005). 
We did not find a consistent adverse effect 
of O3. O3 exhibited a significantly negative 
association with FeNO (Table 4), but a positive 
association with TBARS (Figure 3). The nega-
tive association between O3 concentration and 
FeNO is counterintuitive, because laboratory 
studies have shown that O3 at high concentra-
tions (200–400 ppb) caused inflammation in 
the airways of human subjects (Balmes et al. 
1996; Frampton et al. 1997). In the present 
study, adjusting for co-pollutants and study 
periods in the models did not change the 
results. A sound interpretation for this result 
remains to be found at this point in time.
When a large number of regression mod-
els are run on a data set, some statistically 
significant associations may occur by chance. 
To reduce the possibility of spurious relation-
ships due to multiple comparisons, we limited 
sensitivity analyses to those that consistently 
demonstrated statistical significance in base 
models, and considered only results showing a 
consistent pattern as actual effects.
Conclusion
Results from our study demonstrate a sig-
nificant decrement in small airway function 
and an increase in airway oxidative stress in 
asthmatic children in association with SO2, 
NO2, and PM2.5 in ambient air. TBARS in 
breath condensate may be a useful tool for 
investigating air pollution-related oxidative 
stress among asthmatic children. ICS seems to 
be able to reduce some of the adverse respira-
tory response to air pollutants.
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